deltatrials
Terminated NA INTERVENTIONAL 6-arm NCT01897441

Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer

Prospective Tissue Collection in Breast Cancer Patients Receiving Preoperative Systemic Therapy

Sponsor: Albert Einstein College of Medicine

Conditions Stage IIA Breast Cancer Stage IIB Breast Cancer Stage IIIA Breast Cancer Stage IIIB Breast Cancer Stage IIIC Breast Cancer Stage IV Breast Cancer
Interventions Cyclophosphamide Cytology Specimen Collection Procedure Doxorubicin Hydrochloride Endocrine therapy Laboratory Biomarker Analysis Paclitaxel Trastuzumab
Updated 16 times since 2017 Last updated: Nov 27, 2024 Started: Jun 30, 2013 Primary completion: Oct 25, 2023 Completion: Oct 25, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Interventional component of study terminated prior to full enrollment

Other terminated trials from Albert Einstein College of Medicine

See all terminations from Albert Einstein College of Medicine

A NA clinical study on Stage IIA Breast Cancer and Stage IIB Breast Cancer, this trial is terminated or withdrawn. The trial is conducted by Albert Einstein College of Medicine and has accumulated 16 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Feb 2018 · 12 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshot~Feb 2019 – ~May 2020 · 15 months · monthly snapshot~May 2020 – ~Sep 2020 · 4 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Aug 2023 · 11 months · monthly snapshot~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2025 · 4 months · monthly snapshot~Jan 2025 – ~Sep 2025 · 8 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

16 versions recorded

  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Jan 2025 — Sep 2025 [monthly]

    Terminated NA

    Status: Active Not Recruiting → Terminated

  3. Sep 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  5. Aug 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

▶ Show 11 earlier versions

  1. Sep 2022 — Aug 2023 [monthly]

    Active Not Recruiting NA

  2. Sep 2021 — Sep 2022 [monthly]

    Active Not Recruiting NA

  3. Jan 2021 — Sep 2021 [monthly]

    Active Not Recruiting NA

  4. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  5. May 2020 — Sep 2020 [monthly]

    Active Not Recruiting NA

    Status: Recruiting → Active Not Recruiting

  6. Feb 2019 — May 2020 [monthly]

    Recruiting NA

  7. Aug 2018 — Feb 2019 [monthly]

    Recruiting NA

    Status: Unknown Status → Recruiting

  8. Jun 2018 — Aug 2018 [monthly]

    Unknown Status NA

  9. Feb 2018 — Jun 2018 [monthly]

    Unknown Status NA

    Status: Recruiting → Unknown Status

  10. Feb 2017 — Feb 2018 [monthly]

    Recruiting NA

  11. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jun 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Albert Einstein College of Medicine
  • National Cancer Institute (NCI)
Data source: Albert Einstein College of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations